Q3 2024 EPS Estimates for Astrana Health, Inc. Reduced by Analyst (NASDAQ:ASTH)

Astrana Health, Inc. (NASDAQ:ASTH) – William Blair reduced their Q3 2024 earnings per share (EPS) estimates for Astrana Health in a research note issued on Wednesday, August 7th. William Blair analyst R. Daniels now expects that the company will earn $0.30 per share for the quarter, down from their previous estimate of $0.43. The consensus estimate for Astrana Health’s current full-year earnings is $1.42 per share. William Blair also issued estimates for Astrana Health’s Q1 2025 earnings at $0.38 EPS.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.01. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. The company had revenue of $486.30 million during the quarter, compared to analysts’ expectations of $440.68 million. During the same quarter in the prior year, the business posted $0.28 earnings per share. The company’s revenue for the quarter was up 39.7% compared to the same quarter last year.

Several other research analysts have also recently weighed in on ASTH. Baird R W raised Astrana Health to a “strong-buy” rating in a research note on Thursday, May 30th. Robert W. Baird initiated coverage on Astrana Health in a report on Thursday, May 30th. They set an “outperform” rating and a $54.00 target price for the company. Truist Financial upped their target price on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a report on Friday, August 9th. Finally, Stifel Nicolaus upped their target price on Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $55.75.

Astrana Health Stock Performance

NASDAQ:ASTH opened at $47.69 on Monday. Astrana Health has a 1 year low of $28.86 and a 1 year high of $54.27. The company has a market capitalization of $2.67 billion, a PE ratio of 36.13, a price-to-earnings-growth ratio of 1.83 and a beta of 1.16. The stock has a fifty day simple moving average of $44.55. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.52 and a current ratio of 1.52.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.